Oestrogen producing enzymes and mammary carcinogenesis
Taxane vs. taxane
Nipple aspirate fluids from women with breast cancer contain increased levels of group IIa secretory phospholipase A2
Seasonal modulation of post-resection breast cancer metastasis
Urokinase receptor splice variant uPAR-del4/5-associated gene expression in breast cancer
Additive effects of a prolactin receptor antagonist, G129R, and herceptin on inhibition of HER2-overexpressing breast cancer cells
2-MeOE2bisMATE and 2-EtE2bisMATE induce cell cycle arrest and apoptosis in breast cancer xenografts as shown by a novel ex vivo technique
Adjuvant chemotherapy for breast cancer
Vitamin supplement use and risk for breast cancer
Polymorphisms in three base excision repair genes and breast cancer risk in Thai women
Benign breast disease heterogeneity
On the avoidability of breast cancer in industrialized societies
Distant disease-free interval, site of first relapse and post-relapse survival in BRCA1- and BRCA2-associated compared to sporadic breast cancer patients
Paget's disease of the nipple in a population based cohort
EGF promoter SNPs, plasma EGF levels and risk of breast cancer in Chinese women
Is obesity an independent prognosis factor in woman breast cancer?
Development of a high sensitivity, nested Q-PCR assay for mouse and human aromatase
Development of a high sensitivity, nested Q-PCR assay for mouse and human aromatase
The significance of circulating epithelial cells in Breast Cancer patients by a novel negative selection method
Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitors
Does computer-aided detection (CAD) contribute to the performance of digital mammography in a self-referred population?
Pharmacokinetics and tolerability of exemestane in combination with raloxifene in postmenopausal women with a history of breast cancer
Invasiveness gene signature predicts a favorable outcome also in estrogen receptor-positive primary breast cancers treated with adjuvant tamoxifen